Displaying drugs 2201 - 2225 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Momelotinib | 414.469 C23H22N6O2 |  | A Janus Kinase inhibitor used to treat intermediate or high-risk myelofibrosis. | Janus Kinase Inhibitor |
| Zytron | 314.16 C10H14Cl2NO2PS |  | Zytron (DMPA) is under investigation for the treatment and health services research of HIV, Lactation, Contraception, Postpartum Depression, and Immune Cells (Mucosal and Systemic). DMPA has been investigated for the... | Amines / Organophosphorus Compounds / Sulfur Compounds |
| Capmatinib | 412.428 C23H17FN6O |  | A kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping. | Kinase Inhibitor |
| Niraparib | 320.396 C19H20N4O |  | A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Fostemsavir | 583.498 C25H26N7O8P |  | An antiretroviral HIV-1 attachment inhibitor targeted against the gp120 subunit within the HIV-1 gp160 envelope glycoprotein. | Anti-HIV Agents / HIV Fusion Inhibitors |
| Bictegravir | 449.386 C21H18F3N3O5 |  | An integrase inhibitor used to treat HIV infections. | Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Antivirals used in combination for the treatment of HIV infections / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Direct Acting Antivirals / Heterocyclic Compounds, Fused-Ring / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / MATE 1 Inhibitors / MATE inhibitors / Pyridines / UGT1A1 Substrates |
| Tivozanib | 454.863 C22H19ClN4O5 |  | A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. | Protein Kinase Inhibitors / Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| Tilarginine | 188.2275 C7H16N4O2 |  | Tilarginine has been investigated for the basic science, treatment, and diagnostic of Obesity, Type 2 Diabetes, Ocular Physiology, and Regional Blood Flow. | Arginine / Enzyme Inhibitors / Nitric Oxide Synthase, antagonists & inhibitors |
| Baricitinib | 371.42 C16H17N7O2S |  | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. | Selective Immunosuppressants |
| Nifurtimox | 287.29 C10H13N3O5S |  | An antiparasitic drug used for the treatment of Chagas disease (Trypanosoma cruzi infection). | Nitrofuran Derivatives |
| Esketamine | 237.73 C13H16ClNO |  | A NMDA receptor antagonist used for treatment-resistant depression. | Agents producing tachycardia / Anesthetics / Anesthetics, General / Antidepressive Agents / Antidepressive Agents Indicated for Depression / Central Nervous System Agents / Central Nervous System Depressants / Cyclohexanes / Cycloparaffins / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Miscellaneous Antidepressants / Nervous System / NMDA Receptor Antagonists / Non-Competitive N-Methyl D-Aspartate (NMDA) Receptor Antagonists / Psychoanaleptics / Psychotropic Drugs |
| Ertugliflozin | 436.89 C22H25ClO7 |  | An SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Neratinib | 557.05 C30H29ClN6O3 |  | A protein kinase inhibitor used to treat breast cancer that over expresses the HER2 receptor. | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Indium In-111 pentetreotide | 1472.41 C62H80InN12O19S2 |  | Indium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome. | Indium (111In) Compounds |
| Osilodrostat | 227.242 C13H10FN3 |  | An oral inhibitor of cortisol synthesis used to treat Cushing's disease by normalizing hypercortisolism. | Anticorticosteroids |
| Relugolix | 623.64 C29H27F2N7O5S |  | An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. | Anti-Gonadotropin-Releasing Hormones |
| Revefenacin | 597.76 C35H43N5O4 |  | An anticholinergic agent used to treat COPD. | Anticholinergic Agents / Bronchodilator Agents / Muscarinic Antagonists |
| Brexanolone | 318.4935 C21H34O2 |  | Brexanolone is a synthetic neuroactive steroid gamma-aminobutyric acid A (GABA(a)) receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adult women [FDA Label][A176080, A176083, F4063, F4066, F4072]. | Anesthetics / Anticonvulsants / GABA Modulators / Neurotransmitter Agents |
| Infigratinib | 560.475 C26H31Cl2N7O3 |  | An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| Apalutamide | 477.44 C21H15F4N5O2S |  | An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. | Antiandrogens |
| Valbenazine | 418.578 C24H38N2O4 |  | A vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia and chorea associated with Huntington's disease. | Vesicular Monoamine Transporter 2 Inhibitor |
| Deflazacort | 441.524 C25H31NO6 |  | A corticosteroid used to treat Duchenne muscular dystrophy. | Glucocorticoids |
| Abametapir | 184.242 C12H12N2 |  | A pediculicide metalloproteinase used topically in the treatment of head lice infection. | Antiparasitic Products, Insecticides and Repellents / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Ectoparasiticides, Incl. Scabicides / Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents / Matrix Metalloproteinase Inhibitors / Pediculicides / Pyridines |
| Bempedoic acid | 344.492 C19H36O5 |  | A drug used in conjunction with lifestyle modification and/or other agents for the treatment of refractory hypercholesterolemia. | Adenosine Triphosphate-Citrate Lyase Inhibitor / Enzyme Inhibitors / Hypolipidemic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Difelikefalin | 679.863 C36H53N7O6 |  | A kappa opioid receptor agonist used in the treatment of pruritus associated with chronic kidney disease in patients undergoing hemodialysis. | Kappa Opioid Receptor Agonist |
Displaying drugs 2201 - 2225 of 2780 in total